Observation:
Q2 2024: 157,252 (+ more) Updated: Sep 10, 2024 9:10 AM CDTQ2 2024: | 157,252 | |
Q1 2024: | 176,240 | |
Q4 2023: | 165,049 | |
Q3 2023: | 156,660 | |
Q2 2023: | 156,226 | |
View All |
Units:
Millions of Dollars,Frequency:
QuarterlyData in this graph are copyrighted. Please review the copyright information in the series notes before sharing.
Source: U.S. Census Bureau
Release: Quarterly Financial Report
Units: Millions of Dollars, Not Seasonally Adjusted
Frequency: Quarterly
Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf
U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Noncurrent Liabilities [QFR320385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR320385USNO, .